Probiotics in prevention and treatment of cardiovascular diseases
Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the dev...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Polish Ministry of Science and Higher Education
2021-12-01
|
Series: | Herba Polonica |
Subjects: | |
Online Access: | https://doi.org/10.2478/hepo-2021-0026 |
_version_ | 1797708181670985728 |
---|---|
author | Przerwa Filip Kukowka Arnold Kotrych Katarzyna Uzar Izabela |
author_facet | Przerwa Filip Kukowka Arnold Kotrych Katarzyna Uzar Izabela |
author_sort | Przerwa Filip |
collection | DOAJ |
description | Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment. |
first_indexed | 2024-03-12T06:17:35Z |
format | Article |
id | doaj.art-4fad5070fbe44b5c8ea3cd4cb3fdc985 |
institution | Directory Open Access Journal |
issn | 2449-8343 |
language | English |
last_indexed | 2024-03-12T06:17:35Z |
publishDate | 2021-12-01 |
publisher | Polish Ministry of Science and Higher Education |
record_format | Article |
series | Herba Polonica |
spelling | doaj.art-4fad5070fbe44b5c8ea3cd4cb3fdc9852023-09-03T02:25:29ZengPolish Ministry of Science and Higher EducationHerba Polonica2449-83432021-12-01674778510.2478/hepo-2021-0026Probiotics in prevention and treatment of cardiovascular diseasesPrzerwa Filip0Kukowka Arnold1Kotrych Katarzyna2Uzar Izabela3Student Science Club, Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandStudent Science Club, Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandDepartment of General and Dental Radiology, Pomeranian Medical University in Szczecin, Szczecin, PolandDepartment of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandIncreasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment.https://doi.org/10.2478/hepo-2021-0026probioticsgastrointestinal diseasesmicrobiota |
spellingShingle | Przerwa Filip Kukowka Arnold Kotrych Katarzyna Uzar Izabela Probiotics in prevention and treatment of cardiovascular diseases Herba Polonica probiotics gastrointestinal diseases microbiota |
title | Probiotics in prevention and treatment of cardiovascular diseases |
title_full | Probiotics in prevention and treatment of cardiovascular diseases |
title_fullStr | Probiotics in prevention and treatment of cardiovascular diseases |
title_full_unstemmed | Probiotics in prevention and treatment of cardiovascular diseases |
title_short | Probiotics in prevention and treatment of cardiovascular diseases |
title_sort | probiotics in prevention and treatment of cardiovascular diseases |
topic | probiotics gastrointestinal diseases microbiota |
url | https://doi.org/10.2478/hepo-2021-0026 |
work_keys_str_mv | AT przerwafilip probioticsinpreventionandtreatmentofcardiovasculardiseases AT kukowkaarnold probioticsinpreventionandtreatmentofcardiovasculardiseases AT kotrychkatarzyna probioticsinpreventionandtreatmentofcardiovasculardiseases AT uzarizabela probioticsinpreventionandtreatmentofcardiovasculardiseases |